Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Start with Kaiser Permanente and then let the dominoes fall. Huge inroads coming.
You won’t shake the longs. Too much going on with ARYC to cave now.
100,000 more shares at .0660 and .0670. Woo hoo.
Thanks for the article, Edward. Amazing that Theranos went so far based on lies and deception. Shows how far Arrayit can go with the incredible products they have. Can't wait to see where this company ends up in a few years.
That would be so cool if a company like Novartis bought out Arrayit for several billion dollars!! I could live with that.
Mark isn’t looking to complete financials in June or July. He is just hoping for “significant progress” in July.
DD, thanks for your efforts putting all this together-a great resource for all ! The Pacermonitor files were especially helpful in seeing not only what's gone on with the Taub case, but also some of the strategic planning in Fall of 2013 that went on. ARYC has accomplished some of these major goals in the past 5 years, and is on target for much more. Tremendous info!!
Great report DD, thanks!! Most everything about Arrayit is in one place. Pretty powerful.
Agree. Arrayit is going to be huge in the allergy testing arena. And they have so much more than that. Can't wait to see all that's going on.
Yeah, lol is right--that's really a joke. Won't happen here IMO for many reasons, the main one is fins will be released soon. BTW, who is representing ARYC to the SEC?
Thanks
Thanks Billybob! A question for the board. When does the CE come off, when Arrayit files all delinquent reports, or when they begin to file by posting 2014/15? I would guess it's once they are current, which would include all delinquent filings.
Who cares what it does on one morning. Longs know where this is headed, and it's not down.
Definitely getting exciting, isn't it?
It will take a few days still, the derivatives need to go back to RRBB be added in, once 2104/15 completed it is sent to the lawyer for review and then submit to sec takes 1-2 days. Maybe next Friday they will be released
She sure is bird. Some of these upcoming events could make the speed of that fine timepiece increase dramatically!
The audit timeline was affected by derivatives re-calculations (now complete). We are looking forward to the buy-side analyst call. Thanks, Mark
I agree. Arrayit has had to give some answers re. filing financials to folks like the potential big investors Friday. I don't think they would have had the conference call without some positive answer provided re. fins. IMO coming soon, and with those fins, significant share price appreciation.
Arrayit seems to be kicking it on so many levels. Should be a very big summer!
Great chart...yes, primed for a move up above .05. I have a feeling that a nickel will be left in the dust once fins start getting released.
No one needs to impress anyone here. Longs see a fantastic deal with ARYC and should profit greatly (already have)! GLTA who are invested in this gem....
When this perfect storm hits it's going to be one for the ages.
One is free to believe or not believe; buy ARYC or not buy. I’ve been taking opportunity to buy. GLTA investors here. IMO BIG things coming soon!!
You're correct. Food safety is a huge one, and Arrayit has an incredible, portable, low cost solution for that. Throw on top of that, multiple types of cancer diagnostic tests, neurological tests, genetic tests, allergy tests,.... It's incredible what they've got going. It's really hard to believe that ARYC is still under a nickel. That's why I've continued to add.
I bet you're correct. All these conference calls, FDA approval, contracts, etc, etc, wouldn't see the light of day if Arrayit wasn't going to get things right with fins.
Buy-side analysts ("buy-siders") work for buy side money management firms such as mutual funds, pension funds, trusts, and hedge funds. They are incentivised to identify investment opportunities that will improve the net worth of the portfolio they work for.
IMO, we'll see another 10 bagger soon from here, and then another 10 bagger from there, and then....
I'm sure the conference call will address plans for fins and their soon to be complete status.
Good points, and good purchases today! These next 2+ weeks could be explosive.
Yep, picked up over 100K more shares, some under .04. With news of a conference call, with big buyers potentially coming in soon, means no time to waste on acquiring these cheap shares.
ohiotom, glad you're here in ARYC. Patience will bear MUCH fruit. GLTU
I’m not counting on anything, just like I didn’t count on yesterday’s pop.
EOD buying spree again today?
HUGE THANK YOU TO ALL WHO PROVIDED ALL THIS GREAT INFORMATION AND D.D. GREAT JOB! ENJOY THIS GREAT RIDE!! THIS IS THE REAL DEAL!! Thank you
Arrayit moving full speed ahead on the allergy testing. I believe you are correct with your implication.
Absolutely a great start! Can't wait to see the results of this nationwide push, and also to see what's next-so much going on with Arrayit.
Thanks for the heads up, Coach Wayne. Here's one of those "seminal events!"
Arrayit Corporation Announces Nationwide Allergy Testing Sales and Distribution Network
GlobeNewswire•June 18, 2018
Sunnyvale, June 18, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation Announces Nationwide Allergy Testing Sales and Distribution Network
June 18, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that the company has engaged a nationwide network of professional sales representatives (“sales reps”) to sell and distribute the company’s allergy tests across the Continental United States, with focus areas in the Pacific Northwest, West, Southwest, Rocky Mountain, Midwest, Northeast and Southeast regions. The network comprises 1,700 sales professionals including 500 sales reps with specific training in finger stick sampling, blood card collection and microarray technology. This extensive professional network will be used to enroll hospitals, health maintenance organizations (HMOs), doctor’s and dentist’s offices, health clinics and retail stores into the allergy-testing program.
Arrayit allergy tests utilize non-invasive and convenient finger stick sampling and blood card collection, in conjunction with patented and proprietary protein microarray technology, to rapidly and accurately measure immunoglobulin E (IgE) antibodies in the human bloodstream produced by exposure to 120 common food and environmental allergens. Personalized allergy testing assists health care professionals to more easily identify, treat and prevent allergy and asthma by combining molecular testing with a patient’s medical history, symptomology and a physician’s diagnosis. Arrayit allergy tests are manufactured and processed in the company’s Clinical Laboratory Improvement Amendments (CLIA) laboratory licensed by the State of California and the Centers for Medicare and Medicaid Services (CMS), and benchmarked by the leading laboratory proficiency testing organization, the College of American Pathologists (CAP).
Arrayit CEO Rene Schena states, “We perceive significant synergies between our highly automated allergy testing technology and our newly-contracted network of medical sales professionals working on our behalf to promote allergy testing nationally to patients covered by private and public health insurance. Arrayit finger stick allergy tests are particularly beneficial to pediatric patients, special needs children, seniors, and immunotherapy patients requiring testing at frequent intervals.”
Ace, these are exciting times! Multiple Arrayit products could get FDA approval over the next year(s). What a great company!
After thinking about things going on over the weekend, I'm not sure the July 2nd meeting will be for FDA approval of the product in consideration, but will probably happen later this year. Also, I don't think, since there's more work to do by the auditor, that fins will be released prior to July 2nd. I'm still very high on ARYC, but think we're some weeks away from those 2 events happening. I hope I'm wrong...we'll find out soon-just tempering expectations for early July. Plenty of other seminal events could occur in the meantime.
Thanks, Nebula, same to you! Happy Father's Day to all dads, who can be difference makers. In line with your statement, "if this hits, simply do more," I agree. There's an old saying we don't want to follow if great financial success comes through ARYC, "Get all you can, can all you get, sit on the lid, and poison the rest." Rather, the challenge would be to give generously to make a difference in lives. That could be through stock or cash donations, setting up trusts, etc, etc. Let's make a difference!!
It's good to be part of this board...thanks to all who make it special.
I agree, but IMO, with good fins and FDA approval, this could run above $2, but may very well settle back by end of year to $1 to $2. With all that's going on, that range seems to be sustainable.